1. Identification of a highly lethal V3+TP53+ subset in ALK+ lung adenocarcinoma. Issue 1 (30th October 2018) Authors: Christopoulos, P.; Kirchner, M.; Bozorgmehr, F.; Endris, V.; Elsayed, M.; Budczies, J.; Ristau, J.; Penzel, R.; Herth, F.J.; Heussel, C.P.; Eichhorn, M.; Muley, T.; Meister, M.; Fischer, J.R.; Rieken, S.; Lasitschka, F.; Bischoff, H.; Sotillo, R.; Schirmacher, P.; Thomas, M. Journal: International journal of cancer Issue: Volume 144:Issue 1(2019) Page Start: 190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Intrinsic subtypes and risk scores in ER+/HER2-Breast Cancer: a comparison of Prosigna and OncotypeDX risk categories with Ki67. (March 2017) Authors: Sinn, P.; Schneeweiss, A.; Endris, V.; Penzel, R.; Schirmacher, P.; Kirchner, M.; Stenzinger, A. Journal: Breast Issue: Volume 32(2017)Supplement 1 Page Start: S105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PARP inhibition in BRCA2-mutated prostate cancer. (29th September 2016) Authors: Nientiedt, C.; Tolstov, Y.; Volckmar, A.-L.; Endris, V.; Bonekamp, D.; Haberkorn, U.; Jäger, D.; Sültmann, H.; Stenzinger, A.; Hohenfellner, M.; Grüllich, C.; Duensing, S. Journal: Annals of oncology Issue: Volume 28:Number 1(2017) Page Start: 189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Risk stratification of EGFR+ lung cancer diagnosed with panel-based next-generation sequencing. (October 2020) Authors: Christopoulos, P.; Kirchner, M.; Roeper, J.; Saalfeld, F.; Janning, M.; Bozorgmehr, F.; Magios, N.; Kazdal, D.; Volckmar, A.L.; Brückner, L.M.; Bochtler, T.; Kriegsmann, M.; Endris, V.; Penzel, R.; Kriegsmann, K.; Eichhorn, M.; Herth, F.J.F.; Heussel, C.P.; El Shafie, R.A.; Schneider, M.A. Journal: Lung cancer Issue: Volume 148(2020) Page Start: 105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation. (April 2016) Authors: Tinhofer, I.; Budach, V.; Saki, M.; Konschak, R.; Niehr, F.; Jöhrens, K.; Weichert, W.; Linge, A.; Lohaus, F.; Krause, M.; Neumann, K.; Endris, V.; Sak, A.; Stuschke, M.; Balermpas, P.; Rödel, C.; Avlar, M.; Grosu, A.L.; Abdollahi, A.; Debus, J. Journal: European journal of cancer Issue: Volume 57(2016) Page Start: 78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗